U.S. Markets closed

OncoCyte (OCX) Catches Eye: Stock Jumps 7.3%

Zacks Equity Research

OncoCyte Corporation OCX was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.04 to $5.08 in the past one-month time frame.

The company has seen one negative estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.  

OncoCyte currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

OncoCyte Corporation Price

OncoCyte Corporation Price

OncoCyte Corporation price | OncoCyte Corporation Quote

Investors interested in the Medical Services industry may consider a better-ranked stock like Natera, Inc. NTRA, which carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
 
Is OCX going up? Or down? Predict to see what others think:Up or Down

The Could Be the Fastest Way to Grow Wealth in 2019

Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.

These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.

Click here to see these breakthrough stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
OncoCyte Corporation (OCX) : Free Stock Analysis Report
 
Natera, Inc. (NTRA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research